BrainCool Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jon Berg

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	4.8yrs
Proprietà del CEO	n/a
Durata media del management	1.8yrs
Durata media del Consiglio di amministrazione	less than a year

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Jon Berg

4.8yrs

Mandato

Mr. Jon Berg serves as Chief Operating Officer at BrainCool AB (publ) from 2020 and serves as its Chief Executive Officer from February 2024 and served as its Development & Quality Assurance Manager. Mr. B...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jon Berg	CEO & COO	4.8yrs	Nessun dato	Nessun dato
Lotta Valfridsson	Chief Financial Officer	1.8yrs	Nessun dato	0.049% € 14.7k
Jimmy Hedenstjerna	Chief Technology Officer	less than a year	Nessun dato	Nessun dato
Christian Strand	Head of Distribution & Sales	less than a year	Nessun dato	Nessun dato
Oscar Engellau	Executive Director	no data	Nessun dato	Nessun dato
Mohammad Fazel	Head of Clinical Studies	6.8yrs	Nessun dato	Nessun dato

1.8yrs

Durata media

Gestione esperta: Il team dirigenziale di 5YL non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Oscar Engellau	Executive Director	1.8yrs	Nessun dato	Nessun dato
Hans Henriksson	Chairman of the Board	10.8yrs	Nessun dato	Nessun dato
Jens Lindberg	Independent Director	less than a year	Nessun dato	Nessun dato
Klaus Bratlie	Independent Director	less than a year	Nessun dato	Nessun dato
Michelle Hessius	Independent Director	less than a year	Nessun dato	Nessun dato

0.4yrs

Durata media

53yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di 5YL non è considerato esperto (durata media del mandato 0.4 anni), il che suggerisce un nuovo consiglio.

BrainCool Gestione

Gestione criteri di controllo 0/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Braincool AB (Publ) Approves Board Appointments

BrainCool AB (publ) Announces Roger Henriksson Declines Re-Election as Board Member

BrainCool AB (publ) Announces Roger Henriksson Declines Re-Election as Board Member

No independent directors

No independent directors

CEO & Director recently bought €19k worth of stock

Recent updates

Third quarter 2024 earnings released

Second quarter 2024 earnings released

Braincool AB (Publ) Approves Board Appointments

BrainCool AB (publ) Announces Roger Henriksson Declines Re-Election as Board Member

BrainCool AB (publ) Announces Roger Henriksson Declines Re-Election as Board Member

New major risk - Shareholder dilution

BrainCool AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 85.763172 million.

BrainCool AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 85.763172 million.

BrainCool AB (publ) to Report Q3, 2024 Results on Nov 01, 2024

Full year 2023 earnings released

Braincool AB (Publ) Announces Karolinska Starts the Clinical Study PRINCESS 2 with BrainCool's Product RhinoChill® System

New major risk - Share price stability

BrainCool AB (publ) and University of Freiburg Announces Start of Pivotal Clinical Trial (Cottis 2) for Combined Target Temperature Management and Thrombectomy After Ischemic Stroke

Third quarter 2023 earnings released

Braincool AB (Publ) Announces New Clinical Study Evaluating Early Hypothermia Treatment After Cardiac Arrest with the Braincool System and Rhinochill System

American Medical Association Approves New Current Procedural Terminology Code for Cryotherapy Using BrainCool's Cooral System

BrainCool AB (publ) Announces New CPT Code from AMA for Cooral® System supports Pathway to Reimbursement in the U.S

Second quarter 2023 earnings released

Braincool AB (Publ) Introduces Minichill in Japan

Braincool AB (Publ) Announces New Patent Application for Rhinochill Technology Paves the Way for New Possibilities

BrainCool AB (publ) Receives Patent Approval for "Shivering" in the EU for the Product BrainCool System

Braincool AB (Publ) Announces International Clinical Study with Rhinochill®System of Patients with Sudden Cardiac Arrest Obtain Ethical Approval

First quarter 2023 earnings released

BrainCool AB (publ) to Report Q3, 2023 Results on Nov 30, 2023

BraincCool Launches New Commercialization Strategy for Its Breakthrough Product Cooral ®System Aiming for Reimbursement in the U.S

BrainCool AB (publ) to Report Fiscal Year 2022 Results on Feb 28, 2023

Third quarter 2022 earnings released: kr0.17 loss per share (vs kr0.12 loss in 3Q 2021)

No independent directors

BrainCool AB (publ) to Report Q3, 2022 Results on Nov 30, 2022

BrainCool AB (publ) Announces FDA approval of Cooral

Second quarter 2022 earnings released: kr0.18 loss per share (vs kr0.13 loss in 2Q 2021)

First quarter 2022 earnings released: kr0.14 loss per share (vs kr0.12 loss in 1Q 2021)

BrainCool AB (publ) to Report Q1, 2022 Results on May 31, 2022

No independent directors

CEO & Director recently bought €19k worth of stock

CEO & Director recently bought €19k worth of stock

CEO & Director recently bought €19k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: kr0.13 loss per share (vs kr0.15 loss in 2Q 2020)

First quarter 2021 earnings released: kr0.12 loss per share (vs kr0.24 loss in 1Q 2020)

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media

Età media